Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106532063 | 10653206 | 3 | F | 20141201 | 20160819 | 20141215 | 20160827 | EXP | MY-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-59411BI | BOEHRINGER INGELHEIM | 77.82 | YR | M | Y | 68.70000 | KG | 20160827 | MD | COUNTRY NOT SPECIFIED | MY |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106532063 | 10653206 | 1 | PS | BI 1356 | LINAGLIPTIN | 1 | Oral | 5 MG | Y | 108388 | 5 | MG | TABLET | QD | |||||
| 106532063 | 10653206 | 2 | SS | BI 1356 | LINAGLIPTIN | 1 | Oral | Y | 108388 | TABLET | |||||||||
| 106532063 | 10653206 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1 G | Y | 0 | 1 | G | QD | ||||||
| 106532063 | 10653206 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | Y | 0 | ||||||||||
| 106532063 | 10653206 | 5 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 40 MG | 0 | 40 | MG | QD | |||||||
| 106532063 | 10653206 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 1 G | 0 | 1 | G | QD | |||||||
| 106532063 | 10653206 | 7 | C | PERINDOPRIL | PERINDOPRIL | 1 | Oral | 4 MG | 0 | 4 | MG | QD | |||||||
| 106532063 | 10653206 | 8 | C | PERINDOPRIL | PERINDOPRIL | 1 | Oral | 8 MG | 0 | 8 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106532063 | 10653206 | 1 | Type 2 diabetes mellitus |
| 106532063 | 10653206 | 3 | Diabetes mellitus |
| 106532063 | 10653206 | 5 | Dyslipidaemia |
| 106532063 | 10653206 | 6 | Vitamin supplementation |
| 106532063 | 10653206 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106532063 | 10653206 | OT |
| 106532063 | 10653206 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106532063 | 10653206 | Deafness neurosensory | |
| 106532063 | 10653206 | Hypoglycaemia | |
| 106532063 | 10653206 | Vertigo positional |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106532063 | 10653206 | 1 | 20120510 | 0 | ||
| 106532063 | 10653206 | 2 | 20141211 | 0 | ||
| 106532063 | 10653206 | 4 | 20141211 | 0 | ||
| 106532063 | 10653206 | 5 | 20120730 | 0 | ||
| 106532063 | 10653206 | 6 | 20141006 | 0 | ||
| 106532063 | 10653206 | 8 | 20141203 | 0 |